Examining the link between obesity and heart health in ICD patients
Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD) : a Korean Nationwide Cohort Study
This study looks at how obesity affects heart health in Asian patients with an implantable cardioverter-defibrillator (ICD) to see if different measures of obesity make a difference in their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Ajou University School of Medicine Academic / other |
| Locations | 1 site (Suwon, Gyeong-gido) |
| Trial ID | NCT05645965 on ClinicalTrials.gov |
What this trial studies
This observational study investigates how different measures of obesity, such as BMI and waist circumference, affect clinical outcomes in Asian patients who have received an implantable cardioverter-defibrillator (ICD). Utilizing a nationwide cohort from the Korean National Health Insurance Service, the study analyzes data from patients who underwent ICD insertion between 2015 and 2020. It collects comprehensive demographic and health information, including comorbidities and lifestyle factors, to assess the relationship between obesity and cardiovascular morbidity in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are Asian patients who have undergone ICD insertion between January 2015 and December 2020.
Not a fit: Patients under 20 years old, those who had prior ICD insertion before 2015, or individuals with cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how obesity impacts heart health outcomes for patients with ICDs, potentially guiding better management strategies.
How similar studies have performed: While the obesity paradox in cardiovascular health has been explored, this specific association in ICD patients is relatively novel and not extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent implantable cardioverter-defibrillator (ICD) insertion between January 2015 and December 2020 Exclusion Criteria: * Patients aged \<20 years * Patients already taken ICD insertion before 2015 * Patients with cancer
Where this trial is running
Suwon, Gyeong-gido
- Ajou University School of Medicine — Suwon, Gyeong-gido, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Kwang-No LEE
- Email: knlee81@ajou.ac.kr
- Phone: +82-9286-1123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.